Grafa News and Videos — Page 216

Jabil (NYSE:JBL) reported preliminary unaudited fiscal fourth-quarter 2026 revenue of $10.6 billion, with U.S. GAAP operating income of $602 million and diluted earnings per share of $3.76.

Conagra Brands (NYSE:CAG) reported fiscal 2027 first-quarter net income of $174 million, up 6% year over year, as earnings increased despite a 1.4% decline in net sales to $2.6 billion.

Sono-Tek (NASDAQ:SOTK) received three purchase orders totaling approximately $7.19 million from an existing clean energy customer for production-scale coating systems used in advanced solar manufacturing.

FactSet (NYSE:FDS) reported fourth-quarter fiscal 2026 revenue of $634.7 million for the period ended August 31, 2026, with subscription growth contributing to higher revenue while GAAP earnings declined.

Beamr Imaging (NASDAQ:BMR) expects fiscal year 2026 revenue of approximately $4.5 million, representing an estimated increase of about $1.5 million, or 50%, from fiscal year 2025.

Capital Bancorp (NASDAQ:CBNK) agreed to merge into Peoples Bancorp (NASDAQ:PEBO) in an all-stock transaction valued at approximately $728.1 million, creating a combined banking franchise with expanded commercial and specialty lending operations.

The Generation Essentials Group (NYSE:TGE) reported unaudited first-half 2026 net profit of US$22.8 million compared with US$2.1 million a year earlier, supported by business growth and the absence of a prior-year share-based payment expense.

Hormel Foods (NYSE:HRL) signed a definitive agreement to acquire Brakebush Brothers from the Brakebush family for approximately $1.055 billion, adding a processed chicken supplier to its Foodservice business.

Kenon Holdings (NYSE:KEN) agreed to acquire a 25% indirect equity interest in Vicinity District Energy, a U.S. district heating and cooling business, through a transaction valuing 100% of the company at $2.92 billion.

Sagimet Biosciences (NASDAQ:SGMT) announced 52-week results from license partner Ascletis’ Phase 3 open-label extension trial of denifanstat in moderate to severe acne, with treatment success reaching 56.7% among 240 patients.